First-in-class treatment for renal cancer

• Unité de recherche: INNOSUISSE
• Numéro de projet: 44124.1 IP-LS
• Titre du projet anglais: First-in-class treatment for renal cancer

Description succincte (Allemand)

First-in-class treatment for renal cancer

Description succincte (Anglais)

First-in-class treatment for renal cancer

Résumé des résultats (Abstract) (Allemand)

90 % of patients with advanced renal cancer are resistant to immunotherapy. Building on our innovative solution, this project will establish the use of first-in-class molecules targeting a novel resistance mechanism to improve the efficacy of immunotherapy in renal cancer.